NHC
CL icon

Nicholas Hoffman & Company’s Colgate-Palmolive CL Stock Holding History

Nicholas Hoffman & Company’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12M Buy
13,152
+4
+0% +$357 0.03% 137
2025
Q4 		$1.04M Sell
13,148
-244
-2% -$19.1K 0.02% 142
2025
Q3 		$1.07M Sell
13,392
-190
-1% -$16.2K 0.03% 133
2025
Q2 		$1.23M Sell
13,582
-89
-0.7% -$8.13K 0.03% 112
2025
Q1 		$1.28M Buy
13,671
+3
+0% +$269 0.05% 103
2024
Q4 		$1.24M Buy
13,668
+2
+0% +$191 0.05% 103
2024
Q3 		$1.42M Sell
13,666
-871
-6% -$88.8K 0.06% 100
2024
Q2 		$1.41M Buy
14,537
+3
+0% +$277 0.07% 90
2024
Q1 		$1.31M Sell
14,534
-1,029
-7% -$87.2K 0.07% 97
2023
Q4 		$1.24M Buy
15,563
+3
+0% +$226 0.07% 98
2023
Q3 		$1.11M Sell
15,560
-87
-0.6% -$6.5K 0.08% 97
2023
Q2 		$1.21M Buy
15,647
+80
+0.5% +$6.19K 0.05% 97
2023
Q1 		$1.17M Sell
15,567
-217
-1% -$16.1K 0.11% 98
2022
Q4 		$1.24M Sell
15,784
-129
-0.8% -$9.67K 0.13% 98
2022
Q3 		$1.12M Buy
15,913
+141
+0.9% +$11.1K 0.05% 94
2022
Q2 		$1.26M Buy
15,772
+2
+0% +$156 0.06% 85
2022
Q1 		$1.2M Buy
15,770
+1
+0% +$79 0.05% 94
2021
Q4 		$1.35M Sell
15,769
-67
-0.4% -$5.23K 0.04% 80
2021
Q3 		$1.2M Sell
15,836
-1,101
-7% -$87.4K 0.21% 86
2021
Q2 		$1.38M Buy
16,937
+1
+0% +$82 0.25% 74
2021
Q1 		$1.33M Sell
16,936
-124
-0.7% -$9.72K 0.27% 71
2020
Q4 		$1.46M Buy
17,060
+1
+0% +$83 0.34% 54
2020
Q3 		$1.32M Buy
17,059
+29
+0.2% +$2.21K 0.35% 51
2020
Q2 		$1.25M Sell
17,030
-65
-0.4% -$4.62K 0.36% 53
2020
Q1 		$1.13M Sell
17,095
-225
-1% -$15.9K 0.38% 58
2019
Q4 		$1.19M Sell
17,320
-82
-0.5% -$5.59K 0.33% 68
2019
Q3 		$1.28M Hold
17,402
– – 0.39% 57
2019
Q2 		$1.25M Sell
17,402
-78
-0.4% -$5.54K 0.39% 62
2019
Q1 		$1.2M Buy
17,480
+1,151
+7% +$74.3K 0.38% 64
2018
Q4 		$972K Buy
16,329
+90
+0.6% +$5.63K 0.33% 71
2018
Q3 		$1.09M Sell
16,239
-3,028
-16% -$202K 0.37% 62
2018
Q2 		$1.25M Sell
19,267
-42
-0.2% -$2.75K 0.46% 53
2018
Q1 		$1.38M Sell
19,309
-2,344
-11% -$169K 0.54% 45
2017
Q4 		$1.63M Sell
21,653
-73
-0.3% -$5.33K 0.64% 38
2017
Q3 		$1.58M Buy
21,726
+17
+0.1% +$1.23K 0.67% 39
2017
Q2 		$1.61M Sell
21,709
-93
-0.4% -$6.91K 0.73% 34
2017
Q1 		$1.6M Sell
21,802
-2,311
-10% -$162K 0.75% 34
2016
Q4 		$1.58M Sell
24,113
-139
-0.6% -$9.53K 0.8% 31
2016
Q3 		$1.8M Sell
24,252
-532
-2% -$39.3K 0.98% 23
2016
Q2 		$1.81M Buy
+24,784
New +$1.76M 1.05% 24

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Nicholas Hoffman & Company's CL Position: Q1 2026 in Review

Nicholas Hoffman & Company increased its Colgate-Palmolive (CL) stake by 0.03% in Q1 2026, buying an estimated $357 and bringing the position to 13,152 shares worth $1.12M. The position accounts for 0.03% of the portfolio, ranked #137.

Nicholas Hoffman & Company first reported a position in CL in Q2 2016 and has held it in 40 quarters since. The position peaked at $1.81M in Q2 2016. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Nicholas Hoffman & Company held 13,152 shares of Colgate-Palmolive worth $1.12M as of Q1 2026.
  • Nicholas Hoffman & Company bought 4 Colgate-Palmolive shares in Q1 2026, an estimated $357.
  • Colgate-Palmolive made up 0.03% of Nicholas Hoffman & Company's portfolio in Q1 2026, its #137 holding.
  • Nicholas Hoffman & Company first reported a position in Colgate-Palmolive in Q2 2016 and has held it in 40 quarters since.
  • Nicholas Hoffman & Company's Colgate-Palmolive position peaked at $1.81M in Q2 2016.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Nicholas Hoffman & Company's 13F filing for Q1 2026, filed 29 Apr 2026.